Decriminalize California

The California Psilocybin Decriminalization Initiative 2020

An Open Source Initiative

In December of 2018 we typed up a Google Document on how Decriminalize Psychedelic Mushrooms in California for the November 2020 election.

We then shared it with all the stakeholders granting them comment privileges to compile all take notes before submitting to the California State Legislative Counsel.

They sent us a draft back that we then assimilated and then submitted a formal draft toย the California State Attorney Generals Office for a formal title and summary.ย 

Now we are completing a 30 day public comment period before receiving our Fiscal Impact Analysis and Title and Summary to begin collecting signatures.

When the signature collection process begins we will have approximately 180 days to collect 625,000 valid signatures in order to get this on the ballot.


Subscribe to our newsletter to stay up-to-date with the campaign!


* indicates required


Spirit Pharmacist
Spirit Pharmacist
920 Coalition
920 Coalition
School of Soma
School of Soma
Psilocybin Fund


Drug Risk Chart
Reprinted from The Lancet, VOLUME 376, ISSUE 9752,, David J Nutt,Leslie A King,Lawrence D Phillips, Drug harms in the UK: a multicriteria decision analysis, P1558-1565, Copyright 2010, with permission from Elsevier

The United States Food and Drug Administration has designated psilocybin “Breakthrough Therapy” status. Such status is only granted when preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over available therapies.

Results from studies conducted at highly-respected institutions such as Johns Hopkins, New York University, UCLA, and Imperial College London indicate that psilocybin or psilocybin therapy could be used to treat depression, addiction, and end-of-life anxiety.

Close Menu